We also showed a higher circulatory MIC-1 (macrophage inhibitory cytokine, also known as growth and differentiation factor 15 or GDF15) in prostate cancer patients of AA race than in CA and demonstrated inflammation-associated regulation of MIC-115. Here, GDF15 is linked to prostate carcinoma.